Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-28

FDA Approved: VUITY — Original Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved VUITY (pilocarpine hydrochloride) from AbbVie in an Original Application for improving near vision in adults with presbyopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vuity (pilocarpine)

Snippet

ORIG AP for VUITY (PILOCARPINE HYDROCHLORIDE)